Stockscreener 앱 받기
0.2625
1.65%
-0.0044
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire
CODX INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Up 19.5% in May - Defense World
Co-Diagnostics completes first FDA 510(k) application for Co-Dx PCR Pro - TipRanks
Co-Diagnostics Holds Annual Shareholders Meeting - TipRanks
Co-Diagnostics stock hits 52-week low at $0.27 amid market challenges - Investing.com Australia
Major health care company files for bankruptcy to sell assets - TheStreet
HC Wainwright Predicts Co-Diagnostics Q1 Earnings - Defense World
Q2 EPS Estimates for Co-Diagnostics Raised by HC Wainwright - Defense World
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock News - GuruFocus
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - The Manila Times
Co-Diagnostics, Inc. to Participate in D. Boral Capital Inaugural Global Conference on May 14, 2025 - Nasdaq
Co-Diagnostics Unveils Next-Gen PCR Testing Platform to Elite Institutional Investors - Stock Titan
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Q1 2025 Earnings Call Transcript - MarketBeat
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue ... - Yahoo Finance
Co-Diagnostics Reports Q1 2025 Financial Results - TipRanks
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Inc Reports Q1 2025 Earnings: EPS Loss of $0.24 Beats Estimates, Revenue Falls Short at $0.1 Million - GuruFocus
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Examining the Future: Co-Diagnostics's Earnings Outlook - Nasdaq
Resmed acquires virtual diagnostics company VirtuOx - MassDevice
Co-Diagnostics (NASDAQ:CODX) Stock Rating Upgraded by D Boral Capital - Defense World
D. Boral Capital Initiates Coverage of Co-Diagnostics (LSE:0A50) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Relea - GuruFocus
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - GlobeNewswire
Co-Diagnostics Q1 2025 Earnings Coming May 8: Key Executive Team to Present Latest Financial Performance - Stock Titan
Stock Market Recap: Co-Diagnostics Inc (CODX) Concludes at 0.32, a -18.26 Surge/Decline - DWinneX
Co-Diagnostics (NASDAQ:CODX) Now Covered by Analysts at D. Boral Capital - Defense World
Co-Diagnostics expands sales agreement, adds Clear Street as agent By Investing.com - Investing.com Canada
Co-Diagnostics expands sales agreement, adds Clear Street as agent - Investing.com Australia
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
D. Boral Capital Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - Seeking Alpha
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results - Seeking Alpha
Co-Diagnostics Inc (NASDAQ: CODX): Is This The Time To Buy? - Marketing Sentinel
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges - Investing.com Canada
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges By Investing.com - Investing.com South Africa
Many med-tech company supply chains protected from tariffs - BioWorld MedTech
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Yahoo Finance
Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa - MSN
1.05%
0.64%
자본화:
|
볼륨(24시간):